| | First test of gene editing in babies (endpts.com) |
|
1 point by jryb 10 months ago | past
|
| | UHC envisions no-deductible, no-coinsurance plan plans (endpts.com) |
|
1 point by benchtobedside 11 months ago | past
|
| | Isomorphic Labs deals with pharma companies (endpts.com) |
|
19 points by pama on Jan 7, 2024 | past | 2 comments
|
| | DeepMind’s Demis Hassabis unveils his vision for AI’s future in biotech (endpts.com) |
|
3 points by artiver on Sept 27, 2023 | past | 1 comment
|
| | Google DeepMind's AI successor predicts how 71M mutations cause disease (endpts.com) |
|
58 points by birriel on Sept 19, 2023 | past | 7 comments
|
| | Profluent debuts to design proteins with machine learning (endpts.com) |
|
1 point by doener on Jan 30, 2023 | past
|
| | FDA clears second Alzheimer's drug in 'foundational spark' for field (endpts.com) |
|
2 points by benchtobedside on Jan 6, 2023 | past | 1 comment
|
| | Sickle cell gene editing startup halts trial after serious side effect (endpts.com) |
|
1 point by ilamont on Jan 6, 2023 | past
|
| | Eli Lilly pulls millions in Twitter advertising after fake account debacle (endpts.com) |
|
233 points by benchtobedside on Nov 14, 2022 | past | 210 comments
|
| | Astra Zeneca Pulls Patient Data Exposed on GitHub (endpts.com) |
|
5 points by dannykwells on Nov 4, 2022 | past
|
| | FOIA request compels FDA to release vaccine safety data (endpts.com) |
|
3 points by johndcook on March 3, 2022 | past
|
| | Former anti-aging unicorn slashes staff, stops development of hair loss drug (endpts.com) |
|
1 point by ilamont on Feb 8, 2022 | past
|
| | The Silicon Valley-backed effort to reimagine how the world funds science (endpts.com) |
|
2 points by andymatuschak on Jan 5, 2022 | past
|
| | Biogen slashes Aduhelm price in half, foreshadows significant layoffs (endpts.com) |
|
1 point by tima101 on Dec 20, 2021 | past
|
| | Pfizer pushes back FDA submission for pediatric Covid vaccine (endpts.com) |
|
15 points by semenko on Dec 17, 2021 | past | 10 comments
|
| | As Ginkgo looks to clear its name, the feds have come sniffing around (endpts.com) |
|
1 point by IdoRA on Nov 16, 2021 | past
|
| | Compass Pathways' Phase IIb psilocybin trial shows reduced depression symptoms (endpts.com) |
|
82 points by hentrep on Nov 9, 2021 | past | 119 comments
|
| | Alphabet kickstarts new AI drug discovery outfit (endpts.com) |
|
1 point by escot on Nov 5, 2021 | past
|
| | Top FDA vaccine regulators Gruber, Krause stepping down (endpts.com) |
|
9 points by AndrewBissell on Aug 31, 2021 | past | 2 comments
|
| | CRISPR 3.0 (endpts.com) |
|
1 point by randtrain34 on July 18, 2021 | past
|
| | FDA offers scathing review of Emergent plant's sanitary conditions (endpts.com) |
|
1 point by _Microft on April 21, 2021 | past
|
| | Reverie Labs (YC W18) raises $25M to advance cancer programs with AI (endpts.com) |
|
16 points by ankitvgupta on Feb 3, 2021 | past
|
| | Shkreli's legacy disappears as former company becomes Travere Therapeutics (endpts.com) |
|
7 points by ilamont on Nov 16, 2020 | past
|
| | Longevity as a service: Insilico – deep learning on anti-aging (endpts.com) |
|
1 point by bitdeep on July 19, 2020 | past
|
| | Tesla’s Elon Musk teams up with Covid-19 player CureVac for 'RNA microfactories' (endpts.com) |
|
1 point by IdoRA on July 2, 2020 | past
|
| | NIH-directed purge of those with China ties sweeps up Moffitt CEO Alan List (endpts.com) |
|
1 point by vo2maxer on Dec 19, 2019 | past
|
| | Biopharma has abandoned antibiotic development. Here’s why we did, too (endpts.com) |
|
4 points by longdefeat on Dec 16, 2019 | past
|
| | Biopharma has abandoned antibiotic development (endpts.com) |
|
33 points by DyslexicAtheist on Dec 14, 2019 | past | 1 comment
|
| | Biopharma has abandoned antibiotic development (endpts.com) |
|
106 points by refurb on Dec 13, 2019 | past | 66 comments
|
| | Deerfield bets on NYC, blueprints $635M biotech hub in midtown Manhattan (endpts.com) |
|
1 point by escot on Sept 30, 2019 | past
|
|
|
More |